DC

DocGo Inc.

DCGOHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$322.2M
-47.7% YoY
Net Income
-$182.4M
-1012.4% YoY
EBITDA
-$73.5M
-264.9% YoY
Free Cash Flow
$1.7M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▲ RSI OversoldRSI 21.3, below 30, stock may be oversold
Oct 19CONFIRMED▲ RSI OversoldRSI 24.6, below 30, stock may be oversold
About DocGo Inc.

Part of the healthcare sector, DocGo Inc. (DCGO) is listed under Medical Care Facilities. Valued at $26.9M, DCGO is a micro-cap name in its sector. It operates through Mobile Health Services and Transportation Services segments.

Where DCGO stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, DCGO finished 51.85% below its 150-day moving average ($0.54) and 56.67% below its 200-day moving average ($0.60). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is DCGO overbought or oversold?

At the October 20, 2026 close, DCGO's RSI(14) was 21.3, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$26.9M
Fwd P/E6.99
EPS$-1.94
Beta0.97
52W Change-76.2%
Dividend Yield0.00%
ROE-107.8%
Analysis

DocGo Inc. carries $25.9M in total debt against $25.2M in cash reserves — debt is modestly above the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $1.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -107.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $440.5M (2022) to $322.2M (2025), a 27% decline worth watching.

As with any equity investment, DCGO carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence DocGo Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms